Tolerance checkpoints in B-cell development: Johnny B good

被引:32
作者
Tussiwand, Roxane [1 ]
Bosco, Nabil [2 ]
Ceredig, Rhodri [3 ]
Rolink, Antonius G. [1 ]
机构
[1] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland
[2] Nestle Res Ctr, CH-1000 Lausanne, Switzerland
[3] Natl Univ Ireland, NCBES, REMEDI, Galway, Ireland
基金
瑞士国家科学基金会;
关键词
B cells; Negative selection; Positive selection; Receptor editing; Tolerance; SURROGATE-LIGHT-CHAIN; HEAT-STABLE ANTIGEN(HI); PRE-B; BONE-MARROW; LYMPHOCYTE DEVELOPMENT; POSITIVE SELECTION; ALLELIC INCLUSION; AUTOIMMUNE-DISEASE; ESCAPE TOLERANCE; DEFICIENT MICE;
D O I
10.1002/eji.200939633
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B-cell development up to the immature B-cell stage takes place in the bone marrow, while final maturation into mature B cells occurs in the spleen. During differentiation, the precursor and immature B cells have to pass several checkpoints, including those in which they are censored for being auto-reactive, and therefore being potentially dangerous. Numerous studies have shown that the immature B-cell stage in the bone marrow and the transitional B-cell stages in the spleen comprise distinct checkpoints at which auto-reactivity is censored. Recently, evidence has been provided that the large pre-BII stage in the bone marrow, at which the pre-BCR is expressed, is yet another B-cell tolerance checkpoint. Here, we review these findings and speculate on directions for possible further experimentation.
引用
收藏
页码:2317 / 2324
页数:8
相关论文
共 85 条
[41]   B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals [J].
Loder, F ;
Mutschler, B ;
Ray, RJ ;
Paige, CJ ;
Sideras, P ;
Torres, R ;
Lamers, MC ;
Carsetti, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (01) :75-89
[42]   Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J].
Mackay, F ;
Woodcock, SA ;
Lawton, P ;
Ambrose, C ;
Baetscher, M ;
Schneider, P ;
Tschopp, J ;
Browning, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1697-1710
[43]   B-cell tolerance checkpoints in health and autoimmunity [J].
Meffre, Eric ;
Wardemann, Hedda .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (06) :632-638
[44]   Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells [J].
Melchers, F ;
ten Boekel, E ;
Seidl, T ;
Kong, XC ;
Yamagami, T ;
Onishi, K ;
Shimizu, T ;
Rolink, AG ;
Andersson, J .
IMMUNOLOGICAL REVIEWS, 2000, 175 :33-46
[45]   Identification of anergic B cells within a wild-type repertoire [J].
Merrell, Kevin T. ;
Benschop, Robert J. ;
Gauld, Stephen B. ;
Aviszus, Katja ;
Decote-Ricardo, Debora ;
Wysocki, Lawrence J. ;
Cambier, John C. .
IMMUNITY, 2006, 25 (06) :953-962
[46]   Reversion of B cell commitment upon loss of Pax5 expression [J].
Mikkola, I ;
Heavey, B ;
Horcher, M ;
Busslinger, M .
SCIENCE, 2002, 297 (5578) :110-113
[47]   Revising B cell receptors [J].
Nemazee, D ;
Weigert, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (11) :1813-1817
[48]   Receptor editing in lymphocyte development and central tolerance [J].
Nemazee, David .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (10) :728-740
[49]  
Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076
[50]   The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling [J].
Ohnishi, K ;
Melchers, F .
NATURE IMMUNOLOGY, 2003, 4 (09) :849-856